You are viewing: Latin America Plasma Fractionation Market analysis
Part of: Plasma Fractionation Market (Global)

The Latin America Plasma Fractionation Market was valued at $2035.3 Million in 2026 and projected to reach to $2826.1 Million by 2031, representing a compound annual growth rate of CAGR 6.8%. Latin America's plasma fractionation market is positioned for sustained expansion through 2031, driven by improving healthcare infrastructure, rising chronic disease prevalence, and increased access to plasma-derived therapies.

Latin America Plasma Fractionation Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Latin America Plasma Fractionation Market Trends and Insights

  • In Latin America, this expansion is driven by increasing demand for immunoglobulin therapies, clotting factor concentrates, and albumin products across the region's healthcare systems.
  • Latin America's market growth reflects rising prevalence of bleeding disorders, immunodeficiency conditions, and improved patient access to plasma-derived therapies. The Latin America plasma fractionation market is supported by strengthening regulatory frameworks and growing investments in blood collection infrastructure across the region.
  • In Latin America, key drivers include an aging population, enhanced clinical awareness of plasma therapies, and partnerships between regional manufacturers and international plasma collection organizations.
  • Latin America's competitive landscape features both established multinational players and emerging regional manufacturers expanding production capacity to meet growing demand through 2031..

Key Market Statistics

  • CAGR (2026-2031) CAGR 6.8%
  • Market Size, 2026 ~USD 2035.3 Million
  • Forecast, 2031 ~USD 2826.1 Million
  • Geography Latin America

Latin America Plasma Fractionation Market Overview

Strong Regional Growth Trajectory :

Latin America's plasma fractionation market is expanding at a CAGR of 6.8%, growing from USD 2,035.3 million in 2026 to USD 2,826.1 million by 2031, demonstrating robust demand for blood-derived therapeutics across the region.

Rising Immunoglobulin Demand :

Increasing prevalence of immunodeficiency disorders and autoimmune diseases in Latin America is driving significant demand for immunoglobulin therapies, a key plasma fractionation product category.

Clotting Factor Market Expansion :

Growing awareness and improved diagnosis of bleeding disorders across Latin American healthcare systems are boosting adoption of clotting factor concentrates and hemophilia treatments.

Brazil and Mexico Lead Regional Growth :

Brazil (USD 1,177.4 million) and Mexico (USD 733.1 million) represent the largest markets in Latin America, accounting for the majority of regional plasma fractionation demand and investment opportunities.

Latin America Plasma Fractionation Market Dynamics

  • The region's growing middle class and enhanced reimbursement policies are facilitating broader adoption of immunoglobulin products, albumin, and clotting factors across both public and private healthcare systems. Key growth catalysts include expanding blood collection networks, regulatory harmonization efforts, and rising investments in plasma fractionation facilities.
  • However, challenges such as supply chain constraints, pricing pressures, and regulatory complexities remain.
  • Strategic partnerships between regional manufacturers and international plasma companies are expected to accelerate market penetration, particularly in emerging markets within Central America and the Caribbean..

Market Ecosystem

logo-mobile

PLASMA FRACTIONATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Implemented the Horizon 2 plasma fractionation process at its Kankakee facility to improve immunoglobulin recovery from donated plasma Higher immunoglobulin yield | Improved plasma utilization | Greater production efficiency | Increased supply capacity
company logo
Implemented process improvements through its One Day Batch Release program at plasma-derived therapy manufacturing sites to accelerate batch release Faster batch release | Improved manufacturing efficiency | Shorter lead times | Faster product availability

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • SANOFI
    • Pfizer Inc.
    • NOVARTIS

      Key Takeaways

      • Latin America's plasma fractionation market will grow from USD 2,035.3 million (2026) to USD 2,826.1 million (2031) at a 6.8% CAGR.
      • In Latin America, immunoglobulin therapies and clotting factor concentrates represent the largest demand segments driving market expansion.
      • Latin America's market growth is supported by improved regulatory frameworks, expanded blood collection infrastructure, and rising clinical awareness.
      • Latin America's competitive environment includes both multinational corporations and regional manufacturers investing in production capacity expansion.

      Plasma Fractionation Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SCIG (Type)
      Forecast Period 2026-2030
      Growth Rate CAGR of 7.6% from 2026 to 2030
      Largest Segment THERAPEUTICS (Application)
      Market Size Base Year (Billions) ~USD 36.46 (2026)
      Revenue Forecast (Billions) ~USD 48.87 (2030)
      Segments Covered Product, Type, Application, Therapeutic Area, End User

      Latin America Plasma Fractionation Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Albumin
      • Coagulation Factor Concentrates
      • Immunoglobulins
      • Other Plasma Products
      • Protease Inhibitors

      By Type

      • Factor Ix
      • Factor Viii
      • Factor Xiii
      • Fibrinogen Concentrates
      • Ivig
      • Other Coagulation
      • Other Coagulation Factor Concentrates
      • Other Immunoglobulins
      • Prothrombin Complex Concentrates
      • Prothrombin Factor Concentrates
      • Scig
      • Von Willebrand Factor

      By Application

      • Academics & Preclinical Research
      • Therapeutics

      By Therapeutic Area

      • Critical Care
      • Hemato-Oncology
      • Hematology
      • Immunology
      • Neurology
      • Other Therapeutic Areas
      • Pulmonology
      • Rheumatology

      By End User

      • Home Care Settings & Infusion Centers
      • Hospitals & Specialty Clinics
      • Other End Users

      Target Audience

      • Plasma Fractionation Manufacturers : Regional and international manufacturers need Latin America-specific market data to identify expansion opportunities, optimize production capacity, and develop localized product strategies for Brazil, Mexico, and emerging markets.
      • Healthcare Providers & Hospital Networks : Hospital systems and healthcare networks require market intelligence on plasma product availability, pricing trends, and demand forecasts to optimize procurement strategies and ensure therapeutic supply continuity.
      • Blood Collection & Processing Organizations : Blood banks and plasma collection centers need regional market insights to guide investment in collection infrastructure, processing capabilities, and fractionation partnerships across Latin America.
      • Pharmaceutical Distributors & Wholesalers : Distribution companies require country-level market data and growth forecasts to optimize inventory management, supplier relationships, and market penetration strategies in Latin American healthcare channels.
      • Healthcare Investors & Private Equity : Investment firms evaluating Latin American healthcare opportunities need comprehensive market sizing and growth projections to assess plasma fractionation sector attractiveness and identify acquisition targets.

      Latin America vs. other regions

      HowLatin America compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 28658.5 Million · 7.8% wtd CAGR ·
      Europe
      ~USD 11986.7 Million · 7.3% wtd CAGR ·
      Asia Pacific
      ~USD 8714.7 Million · 8.4% wtd CAGR ·
      Middle East
      ~USD 988.6 Million · 4.4% wtd CAGR ·

      Countries within Latin America - compare and drill down

      Country2025 size (native)
      BrazilUSD 1177.4 Million
      MexicoUSD 733.1 Million
      Rest Of Latin AmericaUSD 915.7 Million

      Country market size visualization

      Brazil
      USD 1177.4 Million
      Mexico
      USD 733.1 Million
      Rest Of Latin America
      USD 915.7 Million

      Reasons to Buy this Report

      • Country-Level Market Segmentation : Access detailed market sizing for Brazil and Mexico, the region's largest plasma fractionation markets, enabling targeted investment and expansion strategies specific to Latin America's leading economies.
      • Product Category Insights : Understand demand dynamics for immunoglobulin therapies, clotting factor concentrates, and albumin products across Latin American healthcare systems to optimize product portfolios and market positioning.
      • Regional Growth Drivers : Identify key growth catalysts unique to Latin America including healthcare infrastructure improvements, regulatory changes, and disease prevalence trends driving plasma fractionation adoption.
      • Competitive Landscape Analysis : Gain insights into regional competitive dynamics, market consolidation trends, and strategic partnerships shaping the Latin American plasma fractionation sector through 2031.
      • Investment & Expansion Roadmap : Develop data-driven strategies for market entry, facility expansion, and partnership opportunities in Latin America's high-growth plasma fractionation market with 6.8% CAGR potential.

      Frequently asked questions

      What is the projected market size for plasma fractionation in Latin America by 2031?

      Latin America's plasma fractionation market is projected to reach USD 2,826.1 million by 2031, growing from USD 2,035.3 million in 2026.

      What is the CAGR for the plasma fractionation market in Latin America?

      Latin America's plasma fractionation market is expected to grow at a compound annual growth rate (CAGR) of 6.8% between 2026 and 2031.

      Which plasma-derived products drive demand in Latin America?

      In Latin America, immunoglobulin therapies, clotting factor concentrates, and albumin products are the primary drivers of plasma fractionation market demand.

      What factors are supporting growth in Latin America's plasma fractionation market?

      Latin America's market growth is supported by strengthened regulatory frameworks, expanded blood collection infrastructure, an aging population, and increased clinical awareness of plasma therapies.

      Who are the key competitors in Latin America's plasma fractionation market?

      Latin America's plasma fractionation market includes established multinational manufacturers and emerging regional producers expanding production capacity to meet regional demand.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global plasma fractionation market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size..

      Secondary Research

      The secondary sources for this research study include publications from government sources, such as FDA/CBER, EMA, WHO, and national health and regulatory authorities; industry associations, such as the Plasma Protein Therapeutics Association (PPTA), the International Plasma and Fractionation Association (IPFA), and AABB; and commercial databases, such as Bloomberg Business, D&B, Factiva, and relevant trade databases. Additional sources include white papers, annual reports, company house documents, investor presentations, scientific and clinical publications, regulatory filings, patent databases, and product and clinical trial databases. Secondary research was used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the plasma fractionation market. It was also used to obtain important information about key players, market classification, segmentation according to industry trends, the bottom-up approach, and key developments from market and technology perspectives. Secondary data was also used to assess plasma collection capacity, fractionation and manufacturing infrastructure, product portfolios, regulatory frameworks, trade patterns, clinical applications, and regional market trends. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market’s prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information.

      Plasma Fractionation Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the plasma fractionation market. These methods were also used extensively to estimate the size of various market segments.

      Plasma Fractionation Market : Top-Down and Bottom-Up Approach

      Plasma Fractionation Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Plasma-derived therapies are medical treatments based on human plasma. Plasma is the largest component of human blood and contains water, salts, enzymes, antibodies, and other proteins. Before it can be used in medical therapies, it undergoes a fractionation process in which the relevant proteins are separated. Plasma-derived therapies are used to treat a wide range of (rare) diseases, from bleeding disorders and inhibitor deficiencies to primary and secondary immunodeficiencies.

      Key Stakeholders

      • Plasma Fractionation Product Manufacturers and Distributors
      • Pharmaceutical and Biotechnology Companies
      • Healthcare Service Providers (including Hospitals and Clinics)
      • Research and Development (R&D) companies
      • Academic Institutes
      • Government Associations
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and forecast the plasma fractionation market based on product, application, therapeutic area, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall plasma fractionation market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the plasma fractionation market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the plasma fractionation market
      • To benchmark players within the plasma fractionation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Product Analysis

      • Further breakdown of the Rest of Europe Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Asia Pacific Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Latin America Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Middle East Plasma Fractionation Market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

      Get the Full Plasma Fractionation Market Report

      Full forecast, segment splits, and company analysis for all Plasma Fractionation Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status